Patient-derived tumour xenografts as models for oncology drug developmentIntegrating palliative care into the trajectory of cancer careNovel immunotherapies in lymphoid malignanciesThe influence of subclonal resistance mutations on targeted cancer therapyCancer-treatment-induced neurotoxicity--focus on newer treatmentsModern approaches to HLA-haploidentical blood or marrow transplantationAdvances in umbilical cord blood manipulation-from niche to bedsideLung cancer chemoprevention: current status and future prospectsThe role of Internet resources in clinical oncology: promises and challengesCurrent and emerging strategies for the prevention of graft-versus-host diseaseBreast cancer in 2013: Genomics, drug approval, and optimal treatment durationThe development of immunoconjugates for targeted cancer therapyLung cancer-a fractal viewpoint.The molecular pathology of cancerPast, present, and future of radiotherapy for the benefit of patientsCan oncology recapitulate paleontology? Lessons from species extinctionsEarly phase clinical trials of anticancer agents in children and adolescents - an ITCC perspective.Systemic, perioperative management of muscle-invasive bladder cancer and future horizons.Tyrosine kinase inhibitors in chronic myeloid leukaemia: which, when, for whom?Diagnosis of cancer as an emergency: a critical review of current evidence.Imaging biomarker roadmap for cancer studiesCancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?Improving early diagnosis of symptomatic cancer.Addressing unwarranted variations in colorectal cancer outcomes: a conceptual approach.Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination.Population-based screening for cancer: hope and hype.Translating neoadjuvant therapy into survival benefits: one size does not fit all.Image-guided cancer surgery using near-infrared fluorescence.Neurological adverse effects caused by cytotoxic and targeted therapies.Functional imaging in adult and paediatric brain tumours.Vessel caliber--a potential MRI biomarker of tumour response in clinical trials.Haematological cancer: ALL classification-integration of genomic and cytogenetic data.Policy: EU data protection regulation--harming cancer research.Non-invasive metabolic imaging of brain tumours in the era of precision medicine.Correction regarding data on blinatumomab-associated seizures.Charged particles in radiation oncology.Genetics: Splicing the pieces of the chronic lymphocytic leukemia puzzle.Haematological cancer: Prophylactic platelet transfusion is frequently not necessary.VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer.Immunotherapy: Vaccine trials in melanoma -- time for reflection.
P1433
Q24604068-08444BC2-A189-47D8-8A78-565E4B9A32ABQ26776348-4D0E176B-C32C-4378-98D4-DA825AA80CD6Q26777394-815F529A-DA10-4228-A404-43753049CC7BQ26781693-832E9659-E900-4AC3-B264-6AC8D38B3889Q26782604-670260C2-7A48-4060-8F33-373D93BD05A0Q26797506-E959A3E9-BEEE-4A60-BF08-C793D8A013C4Q26824305-CFAE60C7-92C9-4B64-ADF2-1F190DAA4ED5Q26995495-FD07B035-931B-40C5-9D43-2975D51B984EQ27007792-E50E02A6-E46E-4A8D-944D-E84782C9A92DQ27016541-B600DFB8-5E6F-41EC-9E35-CEA16077622EQ27021514-31FB4E7A-9744-475B-B29D-554CEDC99C38Q27021990-C56E7515-4E05-40CB-8E59-C1EA78AEF01FQ27310294-78CCD544-5B47-4059-AACA-5D04FB06840CQ28278125-2E1D93CB-A44B-4433-B429-5D64FC974BF7Q28280008-FF508DD6-1D17-48E8-AF6F-811F35C90965Q28607703-ED1CCCF7-26D9-4838-8D1F-CE452964B20EQ30234441-12D1C445-584A-49E2-BC1E-8DCC214BBE67Q30240816-3621B905-F378-4FFB-A870-64DDFA277E2AQ30242015-7F125E6D-3E1D-4D1B-9838-5DC25A4BF53AQ30242018-DBEB1756-A1F8-43CF-AB0F-35309FF9B1B6Q30242020-6DDA4BF5-6625-456B-94A4-E5A7B1FF212CQ30242051-9A960E1C-2B51-48E9-A99B-628B27B286BCQ30242053-F1905B0A-4229-4DF0-A8BA-5FC419D7644BQ30244450-437F7C03-EE39-41BC-A578-4F7BE2B8A391Q30251438-C0072628-5D27-4361-B726-B95B11E5C4F8Q30251601-BC719C1A-65F4-46F0-BF0C-A3B6926799FEQ30251738-CC333914-33D4-4580-B903-0EE557139493Q30432014-B9FFC8D4-CC9B-40C4-AD1C-DB9197BCCA82Q30448951-2329737F-3DA2-48CC-99F2-51EE9416BFE2Q30577397-F5053776-89AF-4651-8A93-3673929BA6B7Q30651792-2118816A-1CEC-4F3C-B7F0-26DD3C387554Q30835485-AEF8E410-1775-47EE-A1DB-3F1697679692Q30846979-8008FA4F-BF44-4971-9EDB-343482CCE036Q31115540-F42955EC-6AD8-4412-8861-12F073C9B6C2Q31123043-8ACAEDF1-EF09-4673-862A-B156461F8769Q33273594-6F910F3C-27B2-4464-9CB7-C5A177982A95Q33352851-754F1C88-32A0-4539-9197-2DAB3CCE3D3BQ33408843-75C73684-11C6-4C4F-8257-3392C7B55744Q33424301-3B6282DE-9C76-4C56-B0F3-4F283A48CC23Q33434380-9796284A-8C52-452C-8D9A-F3E463A32B6D
P1433
description
begutachtete wissenschaftliche Zeitschrift
@de
peer-reviewed scientific journal
@en
revista científica
@es
rivista scientifica
@it
vědecký časopis
@cs
wetenschappelijk tijdschrift van Nature Publishing Group
@nl
рецензований науковий журнал
@uk
वैज्ञानिक पत्रिका
@hi
英语期刊
@zh
name
Nature Reviews Clinical Oncology
@ast
Nature Reviews Clinical Oncology
@de
Nature Reviews Clinical Oncology
@en
Nature Reviews Clinical Oncology
@es
Nature Reviews Clinical Oncology
@fr
Nature Reviews Clinical Oncology
@id
Nature Reviews Clinical Oncology
@it
Nature Reviews Clinical Oncology
@kk
Nature Reviews Clinical Oncology
@kk-arab
Nature Reviews Clinical Oncology
@kk-latn
type
label
Nature Reviews Clinical Oncology
@ast
Nature Reviews Clinical Oncology
@de
Nature Reviews Clinical Oncology
@en
Nature Reviews Clinical Oncology
@es
Nature Reviews Clinical Oncology
@fr
Nature Reviews Clinical Oncology
@id
Nature Reviews Clinical Oncology
@it
Nature Reviews Clinical Oncology
@kk
Nature Reviews Clinical Oncology
@kk-arab
Nature Reviews Clinical Oncology
@kk-latn
altLabel
Nat Clin Pract Oncol
@de
Nat Rev Clin Oncol
@ru
Nat. Rev. Clin. Oncol.
@ru
Nature Clinical Practice Oncology
@de
Nature Clinical Practice Oncology
@nl
Nature Clinical Practice Oncology
@ru
prefLabel
Nature Reviews Clinical Oncology
@ast
Nature Reviews Clinical Oncology
@de
Nature Reviews Clinical Oncology
@en
Nature Reviews Clinical Oncology
@es
Nature Reviews Clinical Oncology
@fr
Nature Reviews Clinical Oncology
@id
Nature Reviews Clinical Oncology
@it
Nature Reviews Clinical Oncology
@kk
Nature Reviews Clinical Oncology
@kk-arab
Nature Reviews Clinical Oncology
@kk-latn
P3181
P646
P1055
P1156
17700156734
P1250
P1277
P1476
Nature Reviews Clinical Oncology
@en
P2002
NatRevClinOncol
P236
P407
P571
2004-01-01T00:00:00Z